Andrew J. Bayley

Diagnostic Performance of CT/MRI-Based Lymph Node Morphology With Three-Plane Size Measurements in Oral Cavity Cancer.

Journal: Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes

Published: August 03, 2026

Metastatic patterns, outcomes, and prognostic factors in de novo metastatic head and neck cancer by tumor HPV status.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: June 16, 2026

Transition from Oncologist- to Therapist-Led MRI-Guided Ultra-Hypofractionated Adaptive Prostate Radiation Therapy: Evaluation of Early Clinical Outcomes.

Journal: Current oncology (Toronto, Ont.)

Published: May 08, 2026

Clinical Factors and Income Status are Associated with Depression and Anxiety in Head and Neck Cancer Patients.

Journal: Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale

Published: March 19, 2026

Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomes.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 09, 2026

Refining adjuvant radiation therapy decision using a nomogram in major salivary gland carcinoma.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: December 10, 2025

What Is the Impact of Treatment De-Escalation on Patient-Reported Outcomes in Patients With T1-T2 Oropharyngeal Cancers? A Secondary Analysis of the ORATOR Studies.

Journal: International journal of radiation oncology, biology, physics

Published: November 30, 2025

Prognostic Value of Impaired Vocal Cord Mobility in T2N0 Glottic Cancer Treated With IMRT.

Journal: The Laryngoscope

Published: November 03, 2025

Prevalence and Prognostic Value of Individual T4-Defining Radiologic Features in Human Papillomavirus-Positive Oropharyngeal Carcinoma.

Journal: International journal of radiation oncology, biology, physics

Published: September 05, 2025

Radiation vs. trans-oral surgery for treatment de-escalation in HPV-related oropharyngeal cancers: Primary analysis of the ORATOR2 randomized trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 07, 2024

Diagnostic Performance of CT/MRI-Based Lymph Node Morphology With Three-Plane Size Measurements in Oral Cavity Cancer.

Diagnostic Performance of CT/MRI-Based Lymph Node Morphology With Three-Plane Size Measurements in Oral Cavity Cancer.

Metastatic patterns, outcomes, and prognostic factors in de novo metastatic head and neck cancer by tumor HPV status.

Metastatic patterns, outcomes, and prognostic factors in de novo metastatic head and neck cancer by tumor HPV status.

Transition from Oncologist- to Therapist-Led MRI-Guided Ultra-Hypofractionated Adaptive Prostate Radiation Therapy: Evaluation of Early Clinical Outcomes.

Transition from Oncologist- to Therapist-Led MRI-Guided Ultra-Hypofractionated Adaptive Prostate Radiation Therapy: Evaluation of Early Clinical Outcomes.

Clinical Factors and Income Status are Associated with Depression and Anxiety in Head and Neck Cancer Patients.

Clinical Factors and Income Status are Associated with Depression and Anxiety in Head and Neck Cancer Patients.

Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomes.

Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomes.

Refining adjuvant radiation therapy decision using a nomogram in major salivary gland carcinoma.

Refining adjuvant radiation therapy decision using a nomogram in major salivary gland carcinoma.

What Is the Impact of Treatment De-Escalation on Patient-Reported Outcomes in Patients With T1-T2 Oropharyngeal Cancers? A Secondary Analysis of the ORATOR Studies.

What Is the Impact of Treatment De-Escalation on Patient-Reported Outcomes in Patients With T1-T2 Oropharyngeal Cancers? A Secondary Analysis of the ORATOR Studies.

Prognostic Value of Impaired Vocal Cord Mobility in T2N0 Glottic Cancer Treated With IMRT.

Prognostic Value of Impaired Vocal Cord Mobility in T2N0 Glottic Cancer Treated With IMRT.

Prevalence and Prognostic Value of Individual T4-Defining Radiologic Features in Human Papillomavirus-Positive Oropharyngeal Carcinoma.

Prevalence and Prognostic Value of Individual T4-Defining Radiologic Features in Human Papillomavirus-Positive Oropharyngeal Carcinoma.

Stereotactic Body Radiation Therapy for Renal Tumors: A Prospective Phase 2 Clinical Trial.

Stereotactic Body Radiation Therapy for Renal Tumors: A Prospective Phase 2 Clinical Trial.

Cancer stage documentation and accuracy: Single-center retrospective study on oropharyngeal cancers.

Cancer stage documentation and accuracy: Single-center retrospective study on oropharyngeal cancers.

Radiation vs. trans-oral surgery for treatment de-escalation in HPV-related oropharyngeal cancers: Primary analysis of the ORATOR2 randomized trial.

Radiation vs. trans-oral surgery for treatment de-escalation in HPV-related oropharyngeal cancers: Primary analysis of the ORATOR2 randomized trial.